-Stock futures are lower after Thursday's 69-point loss for the Dow, larger 0.4 percent drop for the S&P 500, and 0.1 percent dip for the Nasdaq. Earnings season kicks off in earnest today with several reports from key U.S. banks. We also get December retail sales figures later this morning.
-The yield on the 10-year Treasury bond is at 1.10 percent, with the 2-year yield 96 basis points behind at 0.14 percent.
-Gold is flat at the $1,846 per ounce level. Bitcoin is down to the $37,300 level.
-Asian markets were mostly flat. Hong Kong's Hang Seng index rose 0.5 percent, Shanghai's Shenzhen composite rose just 0.1 percent, and Japan's Nikkei index was down 0.6 percent.
-U.S. crude prices are down 1 percent but still at the $53 a barrel level.
-Gasoline prices continue to rise and are at $2.37 a gallon, national average.
-JPMorgan Chase reported better than expected quarterly earnings and revenues. JPMorgan shares are up 1 percent in the premarket and closed Thursday up about 2 percent for the year so far.
-PNC financial reported better-than-expected revenue and earnings for the fourth quarter. But PNC shares are down 2 percent in the premarket.
-President-elect Biden released his $1.9 trillion COVID-19 stimulus plan, which includes an additional $1,400 stimulus check to all Americans, larger unemployment benefits and extending them through September, and providing $20 billion to the states for COVID-19 vaccine distribution.
-The U.S. has shipped over half a million doses of COVID-19 antibody treatments from Eli Lilly and Regeneron that have the potential to keep high-risk Covid patients out of hospitals, but the Trump administration says hospitals aren't doing enough to administer them to COVID patients.
-Sinopharm, the Chinese state-owned company that is reeling from studies that show its COVID-19 vaccine is only 50 percent effective, says its chairman has stepped down from the board. Sinopharm shares rose 2 percent in Hong Kong trading today, but are still 36 percent down for the year so far.
-Israel will be issuing "immunity passports" to its citizens who have received both doses of the COVID-19 vaccines; giving them more mobility and exemptions from lockdown rules both at home and in some foreign countries.
-Playtika priced its initial public offering at $27 per share, above the target range of $22 to $24 per share. The mobile gaming company’s stock will begin trading today on the Nasdaq.
-Petco jumped 63 percent higher Thursday from its initial public offering price on its first day of trading.
-Poshmark had 2021′s best IPO debut day so far with a jump of nearly 142 percent on day one Thursday.
-Generic pharmaceutical company TEVA is launching a generic version of Merck's NuvaRing birth control device in the U.S. market. Teva shares are up 1 percent in the premarket after closing Thursday up 15 percent for the year so far.
-The number of people killed on the nation's highways rose 4.6 percent in the first nine months of 2020 despite coronavirus lockdowns that curtailed driving early in the year. Authorities blamed the increase on risky driving behavior that developed when there were fewer vehicles on the road early in the pandemic and some drivers used the lack of congestion as an excuse to drive recklessly.
-Jeff Bezos’ Blue Origin aims to fly first passengers on its space tourism rocket as early as April.